Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LumiraDx Limited - Common stock (NQ:LMDX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LumiraDx Limited - Common stock

< Previous 1 2 3 4 5 6 7 Next >
Crude Oil Rises 2%; LumiraDx Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.04% to 34,040.13 while the NASDAQ fell 0.77% to 13,562.00. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak... 
Via Benzinga
Why Is LumiraDx (LMDX) Stock Up 30% Today?
LumiraDx (LMDX) stock is heading higher on Wednesday morning after the company received approval for its Covid and RSV tests. 
Via InvestorPlace
The Latest Analyst Ratings for LumiraDx
Via Benzinga
LumiraDx: Q1 Earnings Insights
Via Benzinga
Earnings Preview For LumiraDx
Via Benzinga
Nasdaq Tumbles 1%; Patterson Companies Earnings Beat Views
U.S. stocks traded mostly lower midway through trading, with Nasdaq Composite dropping over 100 points on Wednesday. 
Via Benzinga
Why Is Cabaletta Bio (CABA) Stock Down 8% Today?
Cabaletta Bio (CABA) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is VCI Global (VCIG) Stock Down 20% Today?
VCI Global (VCIG) stock is taking a beating Wednesday but it's not due to negative news from the business and technology consulting company. 
Via InvestorPlace
Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management... 
Via Benzinga
Analyst Ratings for LumiraDx
Via Benzinga
Raymond James Maintains Outperform Rating for LumiraDx: Here's What You Need To Know
Via Benzinga
Revamping LumiraDx: New Strategic Focus And Cost-Saving Initiatives Announced
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning! 
Via InvestorPlace
LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
From LumiraDx Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
LumiraDx Reports First Quarter 2023 Results
From LumiraDx Inc
Via GlobeNewswire
Earnings Outlook For LumiraDx
Via Benzinga
LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
From LumiraDx Inc
Via GlobeNewswire
LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From LumiraDx Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719. 
Via Benzinga
LumiraDx Announces Strategic Refocus and Cost Restructuring Program
From LumiraDx Inc
Via GlobeNewswire
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
LumiraDx Reports Fourth Quarter and Full Year 2022 Results
From LumiraDx Inc
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
From LumiraDx Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.